Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7568. doi: 10.26355/eurrev_202007_22232.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7, by J. Zhang, W.-H. Gong, Y. Li, H.-Y. Zhang, C.-X. Zhang, published in Eur Rev Med Pharmacol Sci 2019; 23 (15): 6548-6553-DOI: 10.26355/eurrev_201908_18540-PMID: 31378895" has been withdrawn. The Publisher apologizes for any inconvenience
this may cause. httpss://www.europeanreview.org/article/18540.